SCHEMBL28066932

SCHEMBL28066932

N=C=NOC(=O)ON=C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27095789 0.79
SCHEMBL28228537 0.78
SCHEMBL4884653 0.77
SCHEMBL27988433 0.77
SCHEMBL29463955 0.71
SCHEMBL9279259 0.71
SCHEMBL9055158 0.71 TSHR (0.33)
SCHEMBL16589627 0.69
SCHEMBL9136351 0.69
SCHEMBL6844294 0.69 CRBN (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108452378-B 3D biological printing forming method 中山大学附属第一医院 2020-10-23 CN claimed
CN-108310463-B 3D printing biological ink and preparation method thereof 中山大学附属第一医院 2020-10-23 CN disclosed
CN-108452378-B 3D biological printing forming method 中山大学附属第一医院 2020-10-23 CN disclosed
CN-105593215-B 2, 4-or 4, 6-diaminopyrimidine compounds as IDH2 mutant inhibitors for the treatment of cancer 安吉奥斯医药品有限公司 2019-01-15 CN disclosed
CN-105593215-A 2, 4-or 4, 6-diaminopyrimidine compounds as IDH2 mutant inhibitors for the treatment of cancer AGIOS PHARMACEUTICALS INC 2016-05-18 CN disclosed